Bavarian Nordic offentliggør årsrapport for 2020
March 12, 2021 02:02 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 12. marts 2021 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag årsrapporten for 2020. Herunder er et resumé af de finansielle resultater for året samt finansielle...
Bavarian Nordic Publishes Annual Report 2020
March 12, 2021 02:02 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, March 12, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today published its Annual Report for 2020. Below is a summary of the financial performance for the year and financial...
Bavarian Nordic A/S offentliggør gennemførelse af en rettet emission og privatplacering af 5.150.000 nye ordinære aktier
March 09, 2021 18:06 ET
|
Bavarian Nordic A/S
MÅ IKKE UDLEVERES, OFFENTLIGGØRES ELLER DISTRIBUERES, HVERKEN HELT ELLER DELVIST, DIREKTE ELLER INDIREKTE I USA, CANADA, JAPAN, SYDAFRIKA, HONG KONG ELLER AUSTRALIEN, UNDTAGET SOM TILLADT I GÆLDENDE...
Bavarian Nordic A/S Announces Completion of Directed Issue and Private Placement of 5,150,000 New Ordinary Shares
March 09, 2021 18:06 ET
|
Bavarian Nordic A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY...
Bavarian Nordic A/S søger at styrke kapitalgrundlaget og dedikerer sig til en ambitiøs strategi for en lovende COVID-19 vaccinekandidat
March 09, 2021 11:06 ET
|
Bavarian Nordic A/S
MÅ IKKE UDLEVERES, OFFENTLIGGØRES ELLER DISTRIBUERES, HVERKEN HELT ELLER DELVIST, DIREKTE ELLER INDIREKTE I USA, CANADA, JAPAN, SYDAFRIKA, HONG KONG ELLER AUSTRALIEN, UNDTAGET SOM TILLADT I GÆLDENDE...
Bavarian Nordic A/S Seeks to Strengthen its Capital Base and Commits to Ambitious Strategy on Promising COVID-19 Vaccine Candidate
March 09, 2021 11:06 ET
|
Bavarian Nordic A/S
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY...
Bavarian Nordic offentliggør finansielle forventninger til 2021
March 09, 2021 11:05 ET
|
Bavarian Nordic A/S
Som følge af usikkerheden forårsaget af COVID-19 vil selskabets finansielle forventninger til 2021 være mindre specifikke end normalt, indtil der igen er større sigtbarhed i markedet KØBENHAVN,...
Bavarian Nordic Reports 2021 Financial Guidance
March 09, 2021 11:05 ET
|
Bavarian Nordic A/S
Due to the uncertainty created by COVID-19 the outlook for 2021 will be less specific than usual until there is more visibility in the market COPENHAGEN, Denmark, March 9, 2021 – Bavarian Nordic A/S...
Bavarian Nordic Reports Encouraging Preclinical Data for COVID-19 Vaccine Candidate Ahead of First-in-Human Trial
March 08, 2021 01:00 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, March 8, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today preclinical data for the capsid virus like particle (cVLP) COVID-19 vaccine candidate, ABNCoV2,...
Bavarian Nordic rapporterer lovende prækliniske resultater for COVID-19 vaccinekandidat forud for opstart af forsøg i mennesker
March 08, 2021 01:00 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 8. marts 2021 – Bavarian Nordic A/S (OMX: BAVA) rapporterede i dag prækliniske resultater for COVID-19 vaccinekandidaten, ABNCoV2, der er indlicenseret fra AdaptVac og er baseret...